Medical Research
Ros1Ders Inc
SACRAMENTO, CA
Total revenue
$351K
Total expenses
$203K
Net assets
$716K
Grants received
$660K
13 grants
EIN
834490547
Tax year
2024
Mission
The ROS1ders is a global group of patients and caregivers living with ROS1+ cancer. We seek to improve outcomes for all ROS1+ cancers through community, education, and research.
Programs
2 programs
EDUCATION - We offer the following education programs:1. Website shares evidence-based information on ROS1+ cancer, treatments, ROS1 clinicians, clinical trials, and living with the disease.2. Social media posts share news about ROS1+ cancer.3. Newsletter highlights with progress and patient and caregiver tips.4. Webinars and conference and presentations to disseminate information.
RESEARCH- We offer the following programs to assist with research:1. Members donate fresh tumor specimens to create cancer models.2. Pursue real-world data collection. 3. Host gatherings of ROS1 experts to sustain and promote research. 4. Collaborate with key players to improve patient care and access to clinical trials.5. Fund seed grants to attract new research for ROS1+ cancer.
Financials
FY 2024
Revenue
Expenses
People
7 listed
Jeff Milde
Executive Dir.
$20K
12 hrs/wk
Janet Freeman-Daily
President
—
20 hrs/wk
Lisa Goldman
Vice President
—
5 hrs/wk
Lisa Bowden
Sec'ty/Treas
—
5 hrs/wk
Upal Basu Roy
Director
—
0.1 hrs/wk
Steve Weiss
Director
—
0.1 hrs/wk
Amie Parker
Director
—
0.1 hrs/wk
Grants received
Showing 13 of 13
Funded by
$660K from 5 funders · 13 grants · 2020–2024
$361K · 5 grants · 2020–2024
$104K · 4 grants · 2020–2023
$102K · 1 grant · 2020
$75K · 1 grant · 2023
$18K · 2 grants · 2023–2024